Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.
Ries CH
Cancer Cell. 2014 Jun 2;25(6):846-59. doi: 10.1016/j.ccr.2014.05.016
Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530.
Locatelli SL
Clin Cancer Res. 2018 Oct 23;25(3):1098-1112. doi: 10.1158/1078-0432.CCR-18-1133
Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs.
Porta C
Cancer Res. 2020 Apr 7;80(13):2874-2888. doi: 10.1158/0008-5472.CAN-19-2843
TGFβ Triggers miR-143/145 Transfer From Smooth Muscle Cells to Endothelial Cells, Thereby Modulating Vessel Stabilization.
Climent M
Circ Res. 2015 Mar 23;116(11):1753-64. doi: 10.1161/CIRCRESAHA.116.305178
T cell costimulation blockade blunts pressure overload-induced heart failure.
Kallikourdis M
Nat Commun. 2017 Mar 6;8:14680. doi: 10.1038/ncomms14680
The involvement of epigenetics in vascular disease development.
Elia L, Condorelli G
Int J Biochem Cell Biol. 2018 Dec 10;107:27-31. doi: 10.1016/j.biocel.2018.12.005
The epigenetic enzyme DOT1L orchestrates vascular smooth muscle cell-monocyte crosstalk and protects against atherosclerosis via the NF-κB pathway.
Farina FM
Eur Heart J. 43(43):4562-4576. doi: 10.1093/eurheartj/ehac097
The early expansion of anergic NKG2A(pos)/CD56(dim)/CD16(neg) natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation.
Roberto A
Haematologica. 2018 Apr 26;103(8):1390-1402. doi: 10.3324/haematol.2017.186619
The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker.
Cammarota R
J Transl Med. 2010 Nov 8;8:112. doi: 10.1186/1479-5876-8-112
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours.
Galon J
J Pathol. 232(2):199-209. doi: 10.1002/path.4287